
A potent weapon against lymphomas
Researchers from the The Max Delbrück Center (MDC) for Molecular Medicine in the Helmholtz Association…
Researchers from the The Max Delbrück Center (MDC) for Molecular Medicine in the Helmholtz Association…
In a new study, researchers at Uppsala University, Sweden, have been able to show differences…
A study which tracked the long-term outcomes of blood cancer patients involved in the MURANO…
First validated prognostic score offers valuable insights for patients advised to ‘watch and wait’ A…
Ian Olver, University of Adelaide Clive James has left a valuable legacy of astute observation…
Michael Hopkin, The Conversation and Noor Gillani, The Conversation The 2019 Prime Minister’s Prize for…
A combination of two drugs keeps patients with chronic lymphocytic leukaemia disease-free and alive longer…
Researchers at the University of Birmingham have shown that it’s possible to produce a compound…
The Phase III ASCEND study of the Bruton’s Tyrosine Kinase inhibitor (BTKi) acalabrutinib in relapsed…
In patients with chronic lymphocytic leukaemia (CLL), the rate of disease growth is apt to…